Introduction
Naringin is a powerful natural flavonoid primarily found in citrus fruits, recognized for its remarkable antioxidant, anti-inflammatory, and cardioprotective properties. Extensively studied for its role in cardiovascular and metabolic health, naringin also supports liver function and lipid metabolism regulation, making it an increasingly valuable ingredient in the modern nutraceutical landscape.
However, despite its strong biological potential, naringin presents several formulation challenges: its strongly bitter taste, limited solubility, and poor intestinal bioavailability restrict its use in oral formulations and reduce consumer compliance.
Properties and Applications
Naringin’s broad biological activity has led to growing interest across multiple nutraceutical fields:
- Cardiovascular health: helps reduce LDL cholesterol and improve overall lipid profile, promoting vascular elasticity and endothelial balance.
• Antioxidant and anti-inflammatory effects: neutralizes free radicals and limits oxidative stress, contributing to cellular protection and systemic inflammation modulation.
• Liver and metabolic support: promotes hepatic detoxification and supports the metabolism of fats and sugars.
• Emerging applications: recent studies explore its potential neuroprotective and immunomodulatory effects, paving the way for new formulations targeting global wellness and healthy aging.
Formulation Challenges of Naringin
The nutraceutical use of naringin faces important technical limitations:
• Intensely bitter taste, difficult to mask in oral applications.
• Low bioavailability, due to rapid metabolism and variable intestinal absorption.
• Instability and standardization issues, particularly in maintaining consistent titration of active compounds.
For formulators, it is therefore essential to have access to an ingredient that is easy to dose, chemically stable, and sensorially neutral, ensuring consumer adherence and product reliability.
IPS Innovation: Naringin MINIACTIVES® TM
To overcome these limitations, the SURACTIVES® division of IPS has developed Naringin MINIACTIVES® TM, an advanced formulation based on a proprietary multi-layer microencapsulation technology.
This innovative system allows:
• Effective taste masking, ensuring superior palatability and consumer compliance.
• Enhanced protection of the active compound during storage and gastrointestinal transit.
• Uniform distribution and precise dosing, ensuring reproducibility and formulation accuracy.
• Optimized bioaccessability, through gradual spread of the active ingredient.
The MINIACTIVES® TM formulation therefore represents a technologically advanced solution, combining biological effectiveness with sensory comfort, making it ideal for high-performance nutraceutical applications in cardiovascular and metabolic health.
Scientific Validation and Preclinical Studies
The SURACTIVES® division of IPS is actively involved inin vitro preclinical studies using human intestinal organoids and 3D cellular models, designed to assess the effects of its proprietary microencapsulation technologies on absorption, bioaccessibility, and gastrointestinal safety.
Although these studies have not been conducted specifically on naringin, results obtained from other actives processed with MINIACTIVES® and MATRIS® technologies have demonstrated that:
• Improvements in absorption and bioavailability are intrinsic to the technology itself.
• A significant reduction in the impact on gastric and intestinal membranes is consistently observed, confirming superior tolerability and safety.
Building upon these results, IPS is now extending its research to include dedicated preclinical studies on Naringin MINIACTIVES® TM, in collaboration with specialized laboratories, to further validate its efficacy and safety profile.
Formulations and Applications
The versatility of the MINIACTIVES® technology enables Naringin MINIACTIVES® TM to be incorporated into multiple dosage forms, such as:
• Tablets and capsules;
• Single-dose sachets and stick packs;
• Vials with dosing caps;
• SmarTTabs®, for direct compression while maintaining the original release profile.
Conclusion
Naringin MINIACTIVES® TM represents a major technological advancement in the nutraceutical industry, providing a high-value ingredient that combines stability, taste-masking performance, and proven efficacy.
Through continuous scientific research and preclinical validation, the SURACTIVES® division of IPS confirms its commitment to developing innovative, safe, and high-performance technologies—bridging advanced formulation science with real-world consumer benefits.
Note: This article is provided for informational purposes only and does not substitute professional medical advice.
